Furthermore, the herbal alkaloid berberine could significantly protect podocytes via inhibiting Drp1-mediated mitochondrial fission and cell apoptosis, suggesting its use as a new therapeutic drug to treat DKD (Qin et al., 2019). This evidence concerns the gene DNM1L and diabetic kidney disease.